Radiosurgery for Trigeminal Neuralgia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment for trigeminal neuralgia, a condition causing severe facial pain. The focus is on Unframed Virtual Cone radiosurgery, a non-invasive treatment using targeted radiation without a head frame, aiming to increase patient comfort. The researchers aim to determine if this method is effective at one hospital before expanding to other locations. Candidates include those with trigeminal neuralgia not controlled by medication and a recent MRI showing no other pain causes. As an unphased trial, this study offers patients access to innovative treatments that could enhance their quality of life.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Unframed Virtual Cone is safe for trigeminal neuralgia radiosurgery?
Research has shown that the Unframed Virtual Cone treatment for trigeminal neuralgia is generally easy for patients to handle. In one study, all patients reported satisfaction with the procedure and would recommend it to others, indicating good results without major problems.
Another study examined the safety of frameless stereotactic radiosurgery, a precise type of radiation therapy, for people with trigeminal neuralgia. The results indicated that the treatment is safe, with no serious side effects for patients.
Overall, this non-invasive treatment likely carries a lower risk of complications. While these findings are encouraging, discussing any concerns with a healthcare provider before joining a trial is always best.12345Why are researchers excited about this trial?
Researchers are excited about the Unframed Virtual Cone radiosurgery for trigeminal neuralgia because it offers a unique, targeted approach to pain relief. Unlike traditional treatments like medication or invasive surgery, this method uses precise 80 Gy radiation delivered with a face mask, eliminating the need for a rigid frame. This non-invasive technique aims to reduce discomfort and improve patient experience while maintaining accuracy, potentially leading to faster recovery and fewer side effects.
What evidence suggests that this Unframed Virtual Cone radiosurgery is effective for trigeminal neuralgia?
Research has shown that Unframed Virtual Cone radiosurgery, which participants in this trial will receive, can greatly reduce pain for people with trigeminal neuralgia. Studies have found that about 80% of patients experience pain relief within six months after the treatment. One study reported that all patients were satisfied with the procedure after three months and would recommend it to others. This treatment is unique because it uses a frameless and non-invasive method, effectively targeting a larger area. Overall, evidence suggests that this technique is promising for managing trigeminal neuralgia pain.12456
Who Is on the Research Team?
John B. Fiveash
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults with trigeminal neuralgia, a type of facial pain, that's not improved with medication. They should be in stable health (ECOG 0-2), have more than a year to live, and an MRI confirming their pain isn't caused by other issues. It's not for those who've had brain radiation before or have certain conditions like multiple sclerosis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants receive 80 Gy Virtual Cone Radiosurgery unframed (face mask)
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of pain relief and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Unframed Virtual Cone
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor